Xin Hua Wang·2025-08-12 05:38Group 1: Company Developments - Zhongji Health announced plans to acquire 100% equity of Xinjiang Xinye Energy Chemical Co., Ltd. through a share issuance, while also raising funds from up to 35 qualified investors [1] - Following the transaction, Zhongji Health's controlling shareholder will change from Liushi State-owned Assets Company to Xinye Group, with the actual controller changing to Xinjiang State-owned Assets Supervision and Administration Commission [2] - The transaction is classified as a major asset restructuring and will result in a reverse listing, with the target asset exceeding 100% of the corresponding indicators of the listed company [2] Group 2: Financial Performance - For the first nine months of 2024, Zhongji Health reported revenue of 298 million yuan and a net loss attributable to shareholders of 43.54 million yuan [2] - As of September 30, 2024, Zhongji Health's total assets amounted to 1.775 billion yuan, with net assets of 173 million yuan [2] Group 3: Industry Trends - The Ministry of Commerce and the General Administration of Customs announced export controls on tungsten, tellurium, bismuth, molybdenum, and indium to safeguard national security and interests [3] - Over 30 small metal concept stocks, including major players like Luoyang Molybdenum and China Railway, have seen significant performance increases, with nearly 70% of these stocks recording price increases this year [4] - Luoyang Molybdenum is projected to achieve a net profit of approximately 12.8 billion to 14.2 billion yuan in 2024, representing a year-on-year increase of 55.15% to 72.12% due to higher sales volumes and prices of copper and cobalt [5] Group 4: Specific Company Performance - Yunnan Germanium is expected to report a net profit of approximately 46 million to 60 million yuan in 2024, reflecting a year-on-year increase of 559.55% to 760.28% due to rising sales and prices of semiconductor materials and germanium products [6]